1. Boyle P, Maisonneuve P, Napalkov P (1995) Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 46 (Suppl 3A):47–55
2. Beemsterboer PMM, de Koning HJ, Kranse R, Trienekens PH, van der Maas PJ, Schröder FH (1999) PSA-testing and use of DRE before and during a randomised trial of screening for prostate cancer (ERSPC, Rotterdam). Submitted 1999
3. Moller Jensen O, Estéve J, Moller H, Renard H (1990) Cancer in the European Community and its members states. Eur J Cancer 26, No. 11/12, 1167–1256
4. Stanford JL, Stephenson RA, Coyle LM, Cehran J, Correa R, Eley JW, Gililand F, Hankey B, Kolonel LN, Kosary C, Ross R, Severson R, West D (1998) Prostate Cancer Trends 19731995, SEER Program National Cancer Institute. National Cancer Institute Monograph.
http://www.seer.img.nci.nih.gov
5. Franks LM (1954) Latent carcinoma of the prostate. J Path Bact 68:603–616